66495-88-3

Basic information

• Product Name: 3-Hydroxy-2-methoxybenzaldehyde
• Synonyms: Benzaldehyde, 3-hydroxy-2-methoxy-;3-Hydroxy-2-methoxybenzaldehyde ISO 9001：2015 REACH
• CAS NO: 66495-88-3
• Molecular Formula: C₈H₈O₃
• Molecular Weight: 152.15
• Product Categories: Aromatic Aldehydes & Derivatives (substituted);Aromatics, Pharmaceuticals, Intermediates & Fine Chemicals
• Mol File: 66495-88-3.mol
• Article Data: 31

Chemical Properties

• Melting Point: 113-115 °C(Solv: water (7732-18-5))
• Boiling Point: 278.374°C at 760 mmHg
• Flash Point: 115.495°C
• Appearance: /
• Density: 1.232g/cm³
• Vapor Pressure: 0.003mmHg at 25°C
• Refractive Index: 1.588
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 9.25±0.10(Predicted)
• CAS DataBase Reference: 3-Hydroxy-2-methoxybenzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Hydroxy-2-methoxybenzaldehyde(66495-88-3)
• EPA Substance Registry System: 3-Hydroxy-2-methoxybenzaldehyde(66495-88-3)

Safety Data

• Hazardous Substances Data: 66495-88-3(Hazardous Substances Data)

Usage

Uses

Different sources of media describe the Uses of 66495-88-3 differently. You can refer to the following data:
1. 3-Hydroxy-2-methoxybenzaldehyde, can be used as an intermediate for the synthesis of various pharmaceutical compounds. It can be used for the synthesis of analogs of antineoplaston A10, having antitumor activity
2. 3-Hydroxy-2-methoxybenzaldehyde-d3, is the labeled analogue of 3-Hydroxy-2-methoxybenzaldehyde (H825420), which can be used as an intermediate for the synthesis of various pharmaceutical compounds. It can be also used for the synthesis of analogs of antineoplaston A10, having antitumor activity.

InChI:InChI=1/C8H8O3/c1-11-8-6(5-9)3-2-4-7(8)10/h2-5,10H,1H3

Upstream product

• 24677-78-9 2,3-dihydroxybenzaldehyde 
• 74-88-4 methyl iodide 
• 218903-24-3 3-isopropoxy-2-methoxybenzaldehyde 
• 114158-62-2 3-methanesulfonyloxy-2-methoxy-benzaldehyde 

Downstream Products

• 1030857-86-3 (1E,6E)-1-(3-hydroxy-2-methoxyphenyl)-7-(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione 
• 401928-27-6 2-methoxy-3-(trifluoromethanesulphonyloxy)benzaldehyde 
• 652980-83-1 2-methoxy-3-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]benzaldehyde 
• 55559-31-4 7-Hydroxybenzisoxazol 
• 144683-55-6 Acetic acid (2S,3R,4S,5R,6R)-4,5-diacetoxy-6-acetoxymethyl-2-(3-formyl-2-methoxy-4-nitro-phenoxy)-tetrahydro-pyran-3-yl ester 
• 144683-56-7 Acetic acid (2S,3R,4S,5R,6R)-4,5-diacetoxy-6-acetoxymethyl-2-(4-amino-3-formyl-2-methoxy-phenoxy)-tetrahydro-pyran-3-yl ester 
• 144683-57-8 6-Amino-2-methoxy-3-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-benzaldehyde 
• 106662-55-9 4-(2-acetoxy-3-bromo)propyl-3-hydroxy-2-methoxy-benzaldehyde 
• 106662-56-0 4-(3-acetoxy-2-bromo)propyl-3-hydroxy-2-methoxy-benzaldehyde 
• 106662-53-7 3-acetoxy-4-(3-bromo-2-hydroxy)propyl-2-methoxy-benzaldehyde 
• 106662-54-8 3-acetoxy-4-(2-bromo-3-hydroxy)propyl-2-methoxy-benzaldehyde 
• 106662-52-6 3-acetoxy-4-allyl-2-methoxy-benzaldehyde 
• 106662-51-5 4-allyl-3-hydroxy-2-methoxy-benzaldehyde 
• 113250-74-1 [1-(3-Benzyloxy-6-bromo-2-methoxy-phenyl)-meth-(Z)-ylidene]-naphtho[2,3-d][1,3]dioxol-5-yl-amine 

Relevant articles and documents

15-PGDH INHIBITOR

[Problem] To provide a compound having a 15-PGDH inhibitory effect. [Solution] A compound represented by general formula (1) or a pharmacologically acceptable salt thereof.

SUBSTITUTED CHROMEN-4-ONE FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

The present invention provides novel compounds having the general formula: (I) wherein R1 to R10, Gi, G2 and m are as described herein, compositions including the impounds and methods of using the compounds for the treatment of hepatitis B.

SUBSTITUTED-PYRIDINYL COMPOUNDS AND USES THEREOF

The present application relates generally to compounds useful for the treatment and/or enhancement of cognitive dysfunction and negative symptoms associated with CNS disorders where the circuitry involving fast spiking PV+ interneurons and the production of cortical gamma oscillations is disrupted. The subject disclosure enables the manufacture of medicaments as well as compositions containing same for use in methods of therapy and prophylaxis of cognitive dysfunction and negative symptoms.